Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
15 Febrero 2024 - 12:15PM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfica de Acción Histórica
De May 2023 a May 2024